ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 141 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 2.67 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2017 | $1,972,000 | -8.7% | 161,000 | +115.0% | 0.11% | -64.9% |
Q1 2015 | $2,161,000 | +72.1% | 74,900 | +73.0% | 0.30% | +43.1% |
Q4 2014 | $1,256,000 | +158.4% | 43,300 | +12.8% | 0.21% | +189.0% |
Q3 2014 | $486,000 | -24.3% | 38,400 | +19.6% | 0.07% | -23.2% |
Q2 2014 | $642,000 | – | 32,100 | – | 0.10% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management III, LLC | 2,942,203 | $36,042,000 | 9.93% |
Foresite Capital Management II, LLC | 1,043,832 | $12,787,000 | 5.18% |
Redmile Group, LLC | 6,476,766 | $79,340,000 | 3.91% |
DAFNA Capital Management LLC | 346,013 | $4,239,000 | 2.63% |
Cormorant Asset Management, LP | 900,000 | $11,025,000 | 1.95% |
SENZAR ASSET MANAGEMENT, LLC | 641,170 | $7,854,000 | 1.92% |
Asymmetry Capital Management, L.P. | 105,228 | $1,289,000 | 1.50% |
New Leaf Venture Partners, L.L.C. | 171,364 | $2,099,000 | 0.97% |
EMERALD ADVISERS, LLC | 1,578,477 | $19,336,000 | 0.79% |
BB BIOTECH AG | 2,266,008 | $27,759,000 | 0.77% |